Literature DB >> 22868373

Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients.

Syed A Ahmad1, Michael J Edwards, Jeffrey M Sutton, Sanjeet S Grewal, Dennis J Hanseman, Shishir K Maithel, Sameer H Patel, David J Bentram, Sharon M Weber, Clifford S Cho, Emily R Winslow, Charles R Scoggins, Robert C Martin, Hong Jin Kim, Justin J Baker, Nipun B Merchant, Alexander A Parikh, David A Kooby.   

Abstract

OBJECTIVE AND
BACKGROUND: Morbidity, mortality, and length of hospital stay after pancreaticoduodenectomy (PD) have significantly decreased over recent decades. Despite this progress, early readmission rates after PD have been reported as high as 50%. Few reports have delineated factors associated with readmission after PD.
METHODS: The medical records of 6 high-volume institutions were reviewed for patients who underwent PD between 2005 and 2010. Data collection included patient characteristics, medical comorbidities, and perioperative factors. Analysis included readmissions up to 90 days after PD.
RESULTS: A total of 1302 patients underwent PD across all institutions. The 30-day and 90-day readmission rates were 15% and 19%, respectively. The most common reasons for 30-day readmission included infectious complications (n = 65) and delayed gastric emptying (n = 29). The most common reasons for readmission after 90 days included wound infections and intra-abdominal abscess (n = 75) and failure to thrive (n = 38). On multivariate analysis, factors associated with higher readmission rates included a preoperative diagnosis of chronic pancreatitis, higher transfusion requirements, and postoperative complications including intra-abdominal abscess and pancreatic fistula (all P < 0.02). Factors not associated with higher readmission rates included advanced age, body mass index, cardiovascular/pulmonary comorbidities, diabetes, steroid use, Whipple type (standard vs pylorus preserving PD), preoperative endobiliary stenting, and vascular reconstruction.
CONCLUSIONS: These multi-institutional data represent a large experience of PD without the biases typically of single center studies. Factors related to infection, nutritional status, and delayed gastric emptying were the most common reasons for readmission after PD. Postoperative complications including pancreatic fistula predicted higher rates of readmission.

Entities:  

Mesh:

Year:  2012        PMID: 22868373     DOI: 10.1097/SLA.0b013e318265ef0b

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  90 in total

1.  A validated, risk assessment tool for predicting readmission after open ventral hernia repair.

Authors:  P A Baltodano; Y Webb-Vargas; K C Soares; C W Hicks; C M Cooney; P Cornell; K K Burce; T M Pawlik; F E Eckhauser
Journal:  Hernia       Date:  2015-08-19       Impact factor: 4.739

2.  Assessing readmission after general, vascular, and thoracic surgery using ACS-NSQIP.

Authors:  Donald J Lucas; Adil Haider; Elliot Haut; Rebecca Dodson; Christopher L Wolfgang; Nita Ahuja; John Sweeney; Timothy M Pawlik
Journal:  Ann Surg       Date:  2013-09       Impact factor: 12.969

3.  Predictors of Short-Term Readmission After Pancreaticoduodenectomy.

Authors:  Rajesh Ramanathan; Travis Mason; Luke G Wolfe; Brian J Kaplan
Journal:  J Gastrointest Surg       Date:  2018-02-05       Impact factor: 3.452

4.  Readmission After Liver Resection for Intrahepatic Cholangiocarcinoma: a Multi-Institutional Analysis.

Authors:  Gaya Spolverato; Hadia Maqsood; Alessandro Vitale; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; T Clark Gamblin; Carlo Pulitano; Todd W Bauer; Feng Shen; George Poultsides; Shishir Maithel; J Wallis Marsh; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-04-23       Impact factor: 3.452

5.  Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama; Tokio Higaki; Masamichi Moriguchi; Nao Yoshida; Teruyuki Miyazaki; Yoichi Teshima
Journal:  J Gastroenterol       Date:  2015-04-23       Impact factor: 7.527

6.  Specific Medicare Severity-Diagnosis Related Group Codes Increase the Predictability of 30-Day Unplanned Hospital Readmission After Pancreaticoduodenectomy.

Authors:  Dimitrios Xourafas; Katiuscha Merath; Gaya Spolverato; Stanley W Ashley; Jordan M Cloyd; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-07-23       Impact factor: 3.452

7.  Early hospital readmission for gastrointestinal-related complications predicts long-term mortality after pancreatectomy.

Authors:  Caitlin W Hicks; Jeffrey J Tosoian; Rebecca Craig-Schapiro; Vicente Valero; John L Cameron; Frederic E Eckhauser; Kenzo Hirose; Martin A Makary; Timothy M Pawlik; Nita Ahuja; Matthew J Weiss; Christopher L Wolfgang
Journal:  Am J Surg       Date:  2015-06-29       Impact factor: 2.565

8.  Readmission following pancreatectomy: what can be improved?

Authors:  Charity C Glass; Stephen P Gondek; Charles M Vollmer; Mark P Callery; Tara S Kent
Journal:  HPB (Oxford)       Date:  2013-03-12       Impact factor: 3.647

9.  Cost comparison analysis of open versus laparoscopic distal pancreatectomy.

Authors:  Daniel R Rutz; Malcolm H Squires; Shishir K Maithel; Juan M Sarmiento; Joanna W Etra; Sebastian D Perez; William Knechtle; Kenneth Cardona; Maria C Russell; Charles A Staley; John F Sweeney; David A Kooby
Journal:  HPB (Oxford)       Date:  2014-06-16       Impact factor: 3.647

10.  Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical Carcinoma.

Authors:  Javier Valero-Elizondo; Yuhree Kim; Jason D Prescott; Georgios A Margonis; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Jason A Glenn; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; George A Poultsides; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-08-19       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.